Insmed Appoints Paul Hudson, Utpal Koppikar as Independent Directors

Bitget2026/10/20 11:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Insmed appointed Paul Hudson and Utpal Koppikar as independent directors, effective immediately.
Hudson served as Sanofi CEO from September 2019 through February 2026, following his tenure as Novartis Pharmaceuticals CEO from 2016 to 2019.
Koppikar has been Verily Health CFO since April 2023; previously, he served as Atara Biotherapeutics CFO from 2018 to 2023.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insmed Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610200700PR_NEWS_USPR_____NY75518) on October 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Insmed Appoints Paul Hudson, Utpal Koppikar as Independent Directors

You may also like

Crypto prices